Nurses' and Nursing Students' Experiences With Generative Artificial Intelligence in Educational and Clinical Settings: A Scoping Review.

Leishmaniasis is a zoonotic disease caused by parasites of the genus , and transmitted by vector of the subfamily [,]. In Colombia, around 11 million people are at risk of Leishmaniasis infection, with rural workers with low socioeconomic conditions being the most affect. This population additionally faces health care barriers which limit the access to early diagnosis and treatment availability [–]. Among the various clinical manifestations, cutaneous leishmaniasis (CL) is the most prevalent form [], with an incidence of 18.6 cases per 100,000 inhabitants in 2022 []. Systemic meglumine antimoniate (MA) has been used as first-line treatment in patients with CL for over 70 years. However, its use is related with a wide range of side effects [], including cardiac, renal, hepatic and pancreatic toxicity [,]. MA has been also associated with an increasing risk of therapeutic failure (TF), with an estimated prevalence of 23.4% across Latin America [–]. Previous studies have identified several factor associated with TF like age, [,,], lesion size number [] and duration of skin lesion [], species [,,–], geographical location [], compliance therapy [], presence of lymphadenopathies [], weight and previous history of leishmaniasis [,]. The Pan American Health organization (PAHO) currently recommends classifying CL treatment as local or systemic based on lesion characteristics and the feasibility of patient follow up []. Recent studies has reported adequate cure rates with the use of miltefosine as the first systemic treatment option in patients with CL []. However, MA remains widely used in our Colombia due to political and logistical difficulties, as well as the lack of knowledge about the infection among healthcare professionals [].